{"created":"2023-05-15T14:40:54.889125+00:00","id":56107,"links":{},"metadata":{"_buckets":{"deposit":"8ceceb9c-a04f-4227-83bc-c9468012fa82"},"_deposit":{"created_by":1,"id":"56107","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"56107"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00056107","sets":["7"]},"author_link":["574027","574029","574030","574031","574032","574028","574026"],"item_10004_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-03","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"86","bibliographicPageStart":"86","bibliographic_titles":[{"bibliographic_title":"QST　Takasaki　Annual 　Report　2016"}]}]},"item_10004_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"We demonstrate that the use of histone deacetylase inhibitors (HDACi) could sensitize refractory tumor cells well for the heavy-ion therapy. B16F10 murine melanoma cells were treated with several HDACis and followed by irradiations. Thereafter, immunofluorescence microscopy ofγH2AX were carried out. Foci size of γH2AX in γ-ray irradiated cells became bigger by pretreatment with HDACis, although foci size of γH2AX in heavy-ion irradiated cells was almost unchanged by pretreatment with HDACis.","subitem_description_type":"Abstract"}]},"item_10004_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Takasaki Advanced Radiation Research Institute, QST"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"斎藤, 克代 (高崎健康福祉大)"}],"nameIdentifiers":[{"nameIdentifier":"574026","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"舟山, 知夫"}],"nameIdentifiers":[{"nameIdentifier":"574027","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"横田, 裕一郎"}],"nameIdentifiers":[{"nameIdentifier":"574028","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"小林, 泰彦"}],"nameIdentifiers":[{"nameIdentifier":"574029","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"舟山 知夫","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"574030","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"横田 裕一郎","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"574031","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"小林 泰彦","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"574032","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Epigenetic Modifier as a Potential Radiosensitizer for Heavy-ion Therapy on Malignancy (V)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Epigenetic Modifier as a Potential Radiosensitizer for Heavy-ion Therapy on Malignancy (V)"}]},"item_type_id":"10004","owner":"1","path":["7"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-04-26"},"publish_date":"2018-04-26","publish_status":"0","recid":"56107","relation_version_is_last":true,"title":["Epigenetic Modifier as a Potential Radiosensitizer for Heavy-ion Therapy on Malignancy (V)"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T22:41:46.748588+00:00"}